Leaderboards/Meningioma and schwannoma management

Meningioma and schwannoma management

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Valeria Barresi
University of Verona
32
2
Fei Xu
Wuhan University
29
3
Giuseppe Donato
Magna Graecia University
12

Rising Stars Papers

1
Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population
ESMO Open|2024
5 cit.
2
H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2024
3 cit.
3
Coblation assistance in endoscopic repair of skull base cerebrospinal fluid leak: a prospective cohort and single-centre study
The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery|2025
2 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Simeng Lu
Harvard University
99
2
М.А. Тлеубергенов
National Center for Biotechnology
73
3
Ethan W. Hass
University of Central Florida
73
4
Zhenzhen Yin
Harvard University
71
5
Ryotaro Nakazawa
Kanazawa University
69
6
Kenta Ohara
The University of Tokyo
61
7
Rosina Paterra
Fondazione IRCCS Istituto Neurologico Carlo Besta
61
8
Julia Bischoff
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
60
9
Philipp Sievers
German Cancer Research Center
55
10
Mayu Kashiwagi‐Hakozaki
The University of Tokyo
50

Emerging Leaders Papers

1
Molecular signatures define <i>BAP1</i>-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
Neuro-Oncology|2025
11 cit.
2
Merlin immunohistochemistry is a reliable surrogate marker for <i>NF2</i> gene alterations in meningioma
Histopathology|2025
3 cit.
3
Recombinant Human Neuregulin1‐β1 Significantly Reduces Schwannoma Growth in Mice
Annals of Neurology|2025
1 cit.
4
Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas
Acta Neuropathologica Communications|2025
1 cit.
5
Brain Tumors in Pregnancy: A Review of Pathophysiology, Clinical Management, and Ethical Dilemmas
Cancers|2025
1 cit.
6
Expression of the Epidermal Growth Factor Receptor (EGFR) Ligand Heparin-Binding EGF-Like Growth Factor (HB-EGF) in Sinonasal Inverted Papilloma
Cureus|2025
0 cit.
7
A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation
Theranostics|2026
0 cit.
8
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss
Nature Communications|2026
0 cit.
9
Prognostic stratification of chordoid meningiomas: the role of chromosome 1p/22q Loss
Acta Neuropathologica Communications|2026
0 cit.
10
Ex Vivo Characterization Studies Identify Candidate Therapies for the Individualized Care of NF2-Related Schwannomatosis
Cancers|2026
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Wolfgang Wick
Hertie Institute for Clinical Brain Research
99
2
Jill S. Barnholtz‐Sloan
University Health System
94
3
David Capper
German Cancer Research Center
87
4
Gavin P. Dunn
Massachusetts General Hospital
71
5
Meena Upadhyaya
Cardiff University
69
6
C. Oliver Hanemann
University of Plymouth
69
7
Todd C. Hankinson
University of Colorado Anschutz Medical Campus
67
8
Kenneth Aldape
National Institutes of Health
66
9
Matthias Holdhoff
Johns Hopkins University
65
10
David H. Gutmann
Washington University in St. Louis
63

All-Time Leaders Papers

1
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Neuro-Oncology|2013
12.1k cit.
2
DNA methylation-based classification of central nervous system tumours
Nature|2018
3.1k cit.
3
The epidemiology of glioma in adults: a "state of the science" review
Neuro-Oncology|2014
2.3k cit.
4
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
Neuro-Oncology|2018
2.2k cit.
5
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Neuro-Oncology|2015
2.2k cit.
6
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017
Neuro-Oncology|2020
2k cit.
7
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Nature Reviews Clinical Oncology|2020
1.9k cit.
8
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
The Lancet Oncology|2017
1.1k cit.
9
Challenges to curing primary brain tumours
Nature Reviews Clinical Oncology|2019
965 cit.
10
<scp>WHO</scp> 2016 Classification of gliomas
Neuropathology and Applied Neurobiology|2017
817 cit.

Reagents for Meningioma and schwannoma management

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Choline Kinase alpha (D5X9W) Rabbit Monoclonal Antibody

#13422$161
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

CYP1A2 (D2V7S) Mouse Monoclonal Antibody

#14719$158
View Evidence →Cell Signaling Technology

Phospho-FoxO3a (Ser7) Antibody

#14724$362
View Evidence →Cell Signaling Technology

Sec24C (D9M4N) Rabbit Monoclonal Antibody

#14676$161
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Osteopontin/SPP1 (E9Z1D) Rabbit Monoclonal Antibody

Cited in 9 papers
#88742$169
View Evidence →Cell Signaling Technology

GPNMB (E4D7P) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 5 papers
#79846$865
View Evidence →Agilent/Dako

Epithelial Membrane Antigen (EMA)

Cited in 5 papers
#M0613
View Evidence →